Results look outstanding to me. Excellent performance in all product areas and geographical regions, all underpinned by strong R&D. Seqirus seems to be running according to management predictions. I was interested to see (p.9 of report) that they are proceeding to Phase 3 study for CSL 112 (product to reduce cholesterol). That must have been a significant decision, since I presume that Phase 3 studies are expensive.
- Forums
- ASX - By Stock
- CSL
- Ann: Half Year Results Analyst Presentation
Ann: Half Year Results Analyst Presentation, page-7
-
- There are more pages in this discussion • 184 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CSL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$297.66 |
Change
-0.870(0.29%) |
Mkt cap ! $143.8B |
Open | High | Low | Value | Volume |
$297.59 | $298.49 | $296.08 | $171.9M | 578.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 277 | $297.66 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$297.67 | 169 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1714 | 297.600 |
2 | 83 | 297.500 |
2 | 945 | 297.320 |
1 | 75 | 297.250 |
1 | 945 | 297.160 |
Price($) | Vol. | No. |
---|---|---|
298.000 | 10 | 1 |
298.020 | 37 | 1 |
298.100 | 50 | 1 |
298.240 | 945 | 1 |
298.250 | 50 | 1 |
Last trade - 16.10pm 10/07/2024 (20 minute delay) ? |
Featured News
CSL (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online